These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic]. Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978 [TBL] [Abstract][Full Text] [Related]
4. Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis. Wu JC; Chan FK; Wong SK; Lee YT; Leung WK; Sung JJ Aliment Pharmacol Ther; 2002 Mar; 16(3):545-52. PubMed ID: 11876709 [TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Schwizer W; Thumshirn M; Dent J; Guldenschuh I; Menne D; Cathomas G; Fried M Lancet; 2001 Jun; 357(9270):1738-42. PubMed ID: 11403809 [TBL] [Abstract][Full Text] [Related]
6. Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection. Miehlke S; Meining A; Lehn N; Höchter W; Weingart J; Simon T; Krämer W; Klann H; Bolle K; Sommer A; Stolte M; Bayerdörffer E Digestion; 1998; 59(6):646-50. PubMed ID: 9813387 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic options after failed Helicobacter pylori eradication therapy. van der Hulst RW; Weel JF; van der Ende A; ten Kate FJ; Dankert J; Tytgat GN Am J Gastroenterol; 1996 Nov; 91(11):2333-7. PubMed ID: 8931413 [TBL] [Abstract][Full Text] [Related]
8. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients. Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519 [TBL] [Abstract][Full Text] [Related]
9. [Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer]. García-Romero E; del Val A; Garrigues V; Cuquerella J; Higón MD; Barrachina M; Pons V; Bixquert M; Ponce J Gastroenterol Hepatol; 1999 Jan; 22(1):1-6. PubMed ID: 10089703 [TBL] [Abstract][Full Text] [Related]
10. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942 [TBL] [Abstract][Full Text] [Related]
11. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial. Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771 [TBL] [Abstract][Full Text] [Related]
12. De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study. Jonaitis L; Kupčinskas J; Kiudelis G; Kupčinskas L Medicina (Kaunas); 2010; 46(7):454-9. PubMed ID: 20966617 [TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of the eradication of Helicobacter pylori by treatment with omeprazol, amoxicillin, and clarithromycin according to dosage and administration schedule]. Martín Mir ML; Val J; Fuentes J; García S; Yus C; Simón MA; Gomollón F Gastroenterol Hepatol; 1998 Nov; 21(9):432-6. PubMed ID: 9882932 [TBL] [Abstract][Full Text] [Related]
14. A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori. Chu KM; Choi HK; Tuen HH; Law SY; Branicki FJ; Wong J Am J Gastroenterol; 1998 Sep; 93(9):1436-42. PubMed ID: 9732921 [TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis. Tursi A; Cammarota G; Papa A; Montalto M; Fedeli G; Gasbarrini G J Clin Gastroenterol; 1996 Sep; 23(2):157-8. PubMed ID: 8877648 [No Abstract] [Full Text] [Related]
16. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Lind T; Mégraud F; Unge P; Bayerdörffer E; O'morain C; Spiller R; Veldhuyzen Van Zanten S; Bardhan KD; Hellblom M; Wrangstadh M; Zeijlon L; Cederberg C Gastroenterology; 1999 Feb; 116(2):248-53. PubMed ID: 9922303 [TBL] [Abstract][Full Text] [Related]
17. [Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy]. Iwasaki A Nihon Rinsho; 1999 Jan; 57(1):127-33. PubMed ID: 10036949 [TBL] [Abstract][Full Text] [Related]
18. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. Avidan B; Melzer E; Keller N; Bar-Meir S Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370 [TBL] [Abstract][Full Text] [Related]
19. Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication. Molina-Infante J; Perez-Gallardo B; Fernandez-Bermejo M; Hernandez-Alonso M; Vinagre G; Dueñas C; Mateos-Rodriguez JM; Gonzalez-Garcia G; Abadia EG; Gisbert JP Aliment Pharmacol Ther; 2010 May; 31(10):1077-84. PubMed ID: 20180787 [TBL] [Abstract][Full Text] [Related]
20. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S; J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]